Literature DB >> 22257240

GreenLight HPS™ 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation.

João Antonio Pereira-Correia1, Karlo Danilson de Moraes Sousa, João Bosco Pinheiro Santos, Daniel de Morais Perpétuo, Luiz Felipe Lopes-da-Silva, Renato Lages Krambeck, Valter José Fernandes Muller, Fernando Pires Vaz.   

Abstract

UNLABELLED: What's known on the subject? and What does the study add? Photovaporization of the prostate (PVP) is now challenging TURP as the standard treatment for lower LUTS caused by BPH. The learning curve for PVP is short and the main advantages of this method over TURP are a shorter period of hospitalization, a shorter period of postoperative vesical catheterization, lower levels of retrograde ejaculation, rare development of dilutional hyponatraemia syndrome, the lack of a need for postoperative vesical irrigation as a result of extremely low indices of postoperative haematuria, and the lack of a need to suspend anticoagulant medication for the surgery. Traditionally, comparisons of the effectiveness of TURP vs PVP have involved parameters such as peak flow urinary rate and post-void residual urine volume measurements, and have employed questionnaires such as the IPSS and the International Index of Erectile Function instruments. However, studies evaluating detailed urodynamic parameters remain scarce and non-comparative The present study compared postoperative, medium-term urodynamic parameters among patients receiving TURP and high-power PVP. We consider the present study to be distinctive because it involved a double-blind, detailed functional analysis of the vesical emptying stage over the course of 2 years, and did not simply comprise an evaluation of clinical parameters and uroflowmetrics. We saw a reduction of infravesical obstruction, as shown by the significant reduction of ≥20 cm H(2)O in the mean micturition pressure for the groups studied, as well as a significant reduction in bladder outlet obstruction index. Thus, the present data show that high-power PVP can achieve and maintain the same results as TURP over a period of 24 months regarding an aspect that is particularly important for maintaining vesical health (i.e. detrusor pressure during the evacuation of the bladder). Such urodynamic data describing the functional outcome of PVP are currently missing from the literature.
OBJECTIVE: To assess the impact of GreenLight HPS™ 120-W (American Medical System Incorporation, Minnetonka, MN, USA) laser photovaporization of the prostate (PVP) compared to transurethral resection of the prostate (TURP) on urodynamic results, voiding function and sexual function. PATIENTS AND METHODS: In total, 20 men with intermediate/severe lower urinary tract symptoms as a result of benign prostatic hyperplasia (BPH) were randomly selected and equally divided into two groups: TURP and PVP. Urodynamic evaluation was performed and International Prostate Symptom Score (IPSS), International Index of Erectile Function-5 and International Consultation on Incontinence Questionnaire - Short Form questionnaires were completed. The results were assessed at 2 years.
RESULTS: Mean IPSS scores were reduced in both groups, although they did not differ between the TURP and PVP groups. There was no significant change in International Index of Erectile Function-5 scores. Half of the patients in the PVP group developed urge urinary incontinence with spontaneous resolution. The urodynamic parameters analyzed showed an improvement for both groups, although the values in the TURP group values were not significantly different from those in the PVP group.
CONCLUSIONS: Bladder storage symptoms may represent a major concern, although they are of limited duration in patients undergoing PVP. High-power PVP can achieve and maintain the same results as TURP over a period of 24 months.
© 2012 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2012        PMID: 22257240     DOI: 10.1111/j.1464-410X.2011.10878.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  30 in total

Review 1.  Update on Greenlight laser vaporization (PVP) 2014.

Authors:  Malte Rieken; Alexander Bachmann
Journal:  World J Urol       Date:  2014-11-05       Impact factor: 4.226

2.  [S2e guideline of the German urologists: Instrumental treatment of benign prostatic hyperplasia].

Authors:  T Bschleipfer; T Bach; R Berges; K Dreikorn; C Gratzke; S Madersbacher; M-S Michel; R Muschter; M Oelke; O Reich; C Tschuschke; K Höfner
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

3.  Ablative efficiency of 532-nm laser vaporization compared to transurethral resection of the prostate: results from a prospective three-dimensional ultrasound volumetry study.

Authors:  Thomas Hermanns; Oliver Gross; Benedikt Kranzbühler; Lukas J Hefermehl; Cédric Poyet; Alexander Müller; Stanley A Yap; Maurice S Michel; Daniel Eberli; Michael Müntener; Matthias Zimmermann; Tullio Sulser; Hans-Helge Seifert
Journal:  World J Urol       Date:  2013-10-31       Impact factor: 4.226

4.  Comparison between complication rates of laser prostatectomy electrocautery transurethral resection of the prostate: A population-based study.

Authors:  Alexandre Larouche; Andreas Becker; Jonas Schiffmann; Florian Roghmann; Giorgio Gandaglia; Nawar Hanna; Zhe Tian; Paul Perrotte; Thorsten Schlomm; Markus Graefen; Sascha Ahyai; Quoc-Dien Trinh; Pierre I Karakiewicz; Maxine Sun
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

Review 5.  Role of lasers in urology.

Authors:  Stephan M Korn; Nicolai A Hübner; Christian Seitz; Shahrokh F Shariat; Harun Fajkovic
Journal:  Photochem Photobiol Sci       Date:  2019-02-13       Impact factor: 3.982

Review 6.  Lower Urinary Tract Symptoms Following Transurethral Resection of Prostate.

Authors:  Soo Jeong Kim; Omar Al Hussein Alawamlh; Bilal Chughtai; Richard K Lee
Journal:  Curr Urol Rep       Date:  2018-08-20       Impact factor: 3.092

7.  [Laservaporization of the prostate: current status of the greenlight and diode laser].

Authors:  M Rieken; A Bachmann; C Gratzke
Journal:  Urologe A       Date:  2013-03       Impact factor: 0.639

8.  The 532-nm 180-W (GreenLight®) laser vaporization of the prostate for the treatment of lower urinary tract symptoms: how durable is the new side-fire fiber with integrated cooling system?

Authors:  Claus Brunken; Maximilian Munsch; Stephan Tauber; Rainer Schmidt; Christian Seitz
Journal:  Lasers Med Sci       Date:  2013-04-25       Impact factor: 3.161

9.  Vaporization of the prostate with 150-w thulium laser: complications with 6-month follow-up.

Authors:  César Vargas; Alejandro García-Larrosa; Santiago Capdevila; Ainhoa Laborda
Journal:  J Endourol       Date:  2014-03-31       Impact factor: 2.942

10.  Photoselective green-light laser vaporisation vs. TURP for BPH: meta-analysis.

Authors:  Hui Ding; Wan Du; Ze-Ping Lu; Zhen-Xing Zhai; Han-Zhang Wang; Zhi-Ping Wang
Journal:  Asian J Androl       Date:  2012-08-20       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.